Drug Trial Radar · NCT06074380
Non Inferiority Trial Investigating Surfactants Administered Via MIST
Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
262
Planned (sponsor's estimate)
Start
Jan 1, 2024
Primary completion
Dec 30, 2025
Study completion Dec 1, 2027
Sponsor
- Lead sponsor
- Endeavor HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 48 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 ≥0.30 will randomized to curosurf or infasurf via MIST. Exclusion criteria Infants will be excluded if there is a congenital anomaly or an alternative cause for respiratory distress. Babies who require emergent intubation will not be enrolled in the interventions. Parental Consent will be obtained prior to randomization.
Conditions
- Respiratory Distress Syndrome
Interventions
MIST surfactantDrug
Surfactant will be given via MIST while neonate is on CPAP
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of infants requiring Endotracheal IntubationTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Northshore University Healthsystem
Evanston, Illinois · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.